We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
-9.54%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
AUM
$211M
AUM Growth
-$33.8M
Cap. Flow
+$8.68M
Cap. Flow %
4.11%
Top 10 Hldgs %
54.93%
Holding
56
New
8
Increased
15
Reduced
11
Closed
8

Top Buys

Rank Stock Value
1
ELVA
Electrovaya
ELVA
+$13.1M
2
ASPN icon
Aspen Aerogels
ASPN
+$12.4M
3
ALIM
Alimera Sciences
ALIM
+$7.84M
4
OUST icon
Ouster
OUST
+$7.13M
5
ASRT
Assertio
ASRT
+$3.68M

Sector Composition

Rank Sector Weight
1 Healthcare 50.54%
2 Technology 32.16%
3 Industrials 15.26%
4 Consumer Staples 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIP icon
1
ANI Pharmaceuticals
ANIP
$1.86B
$15.8M 7.5%
272,801
-77,524
-22% -$4.47M
SCPH
2
DELISTED
scPharmaceuticals
SCPH
$15.7M 7.44%
2,207,009
+155,204
+8% +$1.22M
ASPN icon
3
Aspen Aerogels
ASPN
$338M
$15.1M 7.13%
+1,752,022
New +$12.4M
INDI icon
4
indie Semiconductor
INDI
$634M
$13.2M 6.26%
2,100,000
+100,000
+5% +$773K
TGAN
5
DELISTED
Transphorm, Inc. Common Stock
TGAN
$10.3M 4.85%
4,619,558
+206,965
+5% +$578K
TELA icon
6
TELA Bio
TELA
$30.3M
$10M 4.74%
1,252,945
-405,000
-24% -$3.76M
AVNW icon
7
Aviat Networks
AVNW
$253M
$9.91M 4.69%
317,544
-183,179
-37% -$5.79M
ELVA
8
Electrovaya
ELVA
$380M
$9.58M 4.54%
+3,353,308
New +$13.1M
MRAM icon
9
Everspin Technologies
MRAM
$302M
$8.34M 3.95%
848,430
BDSX icon
10
Biodesix
BDSX
$212M
$8.1M 3.83%
245,335
-7,736
-3% -$215K
ALIM
11
DELISTED
Alimera Sciences
ALIM
$7.35M 3.48%
+2,372,572
New +$7.84M
OUST icon
12
Ouster
OUST
$2.1B
$6.49M 3.07%
+1,287,993
New +$7.13M
APYX icon
13
Apyx Medical
APYX
$162M
$6.06M 2.87%
1,895,231
+628,432
+50% +$2.93M
BWAY
14
Brainsway
BWAY
$568M
$5.47M 2.59%
2,710,044
+166,524
+7% +$257K
GSIT icon
15
GSI Technology
GSIT
$202M
$5.42M 2.57%
2,000,000
LPTH icon
16
Lightpath Technologies
LPTH
$593M
$5.4M 2.56%
3,723,932
+335,000
+10% +$560K
ABEO icon
17
Abeona Therapeutics
ABEO
$355M
$4.78M 2.26%
1,135,252
+496,278
+78% +$1.88M
BKTI icon
18
BK Technologies
BKTI
$294M
$4.11M 1.95%
330,896
BWEN icon
19
Broadwind
BWEN
$82.4M
$3.17M 1.5%
991,700
CGTX icon
20
Cognition Therapeutics
CGTX
$80.2M
$2.94M 1.39%
2,038,853
CLNN icon
21
Clene
CLNN
$60.4M
$2.88M 1.36%
290,094
-6,781
-2% -$93.9K
FENC icon
22
Fennec Pharmaceuticals
FENC
$334M
$2.81M 1.33%
373,526
+24,069
+7% +$196K
SPRB
23
Spruce Biosciences
SPRB
$113M
$2.74M 1.3%
16,147
+1,334
+9% +$225K
AIRG icon
24
Airgain
AIRG
$71.5M
$2.65M 1.26%
722,534
MYO icon
25
Myomo
MYO
$35.9M
$2.43M 1.15%
2,188,883
+188,883
+9% +$160K

Similar funds

AIGH Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, AIGH Capital Management held 56 positions worth $211M, down 14% from $245M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

AIGH Capital Management deployed $8.68M of net new capital in Q3 2023, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was Electrovaya: 3,353,308 shares worth $9.58M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 45% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Aviat Networks, an estimated $5.79M trimmed.

  • AIGH Capital Management's largest Q3 2023 buy was Electrovaya: 3,353,308 shares worth $9.58M.
  • AIGH Capital Management added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $3.63M increase.
  • AIGH Capital Management's biggest Q3 2023 reduction was Aviat Networks, cutting an estimated $5.79M.
  • AIGH Capital Management fully exited Microchip Technology in Q3 2023, selling an estimated $22.4M.
  • AIGH Capital Management's ten largest holdings make up 55% of its $211M portfolio in Q3 2023.
  • AIGH Capital Management opened 8 new positions and closed 8 in Q3 2023.
  • AIGH Capital Management's portfolio value fell 14% quarter-over-quarter to $211M.

Based on AIGH Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.